|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
FY2020
12 months to Jun 30, 2020
|
FY2018
12 months to Dec 31, 2017
|
FY2017
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Building and land impairment | |||||
| Stock issued for services | |||||
| Depreciation and amortization of property, equipment and intangibles | |||||
| Loss on disposal of property and equipment | |||||
| Amortization of debt discounts | |||||
| Impairment expense | |||||
| Change in fair value of derivative liability | |||||
| Impairment of goodwill and intangible assets | |||||
| Extinguishment of PPP loan | |||||
| Stock issued for services and donated | |||||
| Non cash interest expense for issuance of common shares as consideration paid under the Equity Purchase Agreement | |||||
| Non cash interest expense for issuance of common shares as consideration paid to reduce liabilities | |||||
| Stock issued under the Equity Purchase Agreement | |||||
| Stock issued for commitment fees | |||||
| Stock issued to reduce liabilities | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Right of use assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Acquisition of business | |||||
| Purchases of property and equipment | |||||
| Capitalization of development costs | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Principal payments on financing lease obligations | |||||
| Principal payments on notes payable | |||||
| Payments on related party notes | |||||
| Payments on convertible notes payable | |||||
| Proceeds from PPP and auto loans | |||||
| Proceeds from convertible notes payable | |||||
| Proceeds from notes payable | |||||
| Proceeds from issuance of common stock | |||||
| Payments on line of credit, net | |||||
| Proceeds from notes payable-related parties | |||||
| Net cash provided by financing activities | |||||
| Net (Decrease) Increase in Cash and Cash Equivalents | |||||
| Cash, Beginning of Period | |||||
| Cash, End of Period | |||||
| Noncash additions related to convertible debt | |||||
| Noncash additions related to notes payable | |||||
| Cash paid for interest | |||||
| Related party note payable issued for acquisition of business | |||||
| Settlement of conversion features | |||||
| Acquisition of intangibles | |||||
| Convertible notes and warrants extinguished | |||||
| Stock issued for services and donated | |||||
| Property and equipment purchased with financing lease | |||||
| Fair value of convertible note issued to stockholder | |||||
| Fair value of preferred stock-Series E issued to stockholder | |||||
| Non-cash principal payments from proceeds of convertible debt | |||||
| Accretion of discount on notes payable | |||||
| Common stock issued in exchange for convertible debt reduction | |||||
| Common stock issued in connection with the Equity Purchase Agreement | |||||
Loading...